KEGG: xau:Xaut_4623
STRING: 78245.Xaut_4623
The nuoK subunit of NADH-quinone oxidoreductase (Complex I) in X. autotrophicus serves as an integral membrane component crucial for proton translocation during the electron transfer process. As one of the membrane-embedded subunits, nuoK forms part of the proton-pumping machinery that couples electron transfer from NADH to quinone with proton translocation across the cytoplasmic membrane . Unlike the Na+-translocating NADH:quinone oxidoreductase (Na+-NQR) found in organisms like Vibrio cholerae, the X. autotrophicus Complex I is a proton-pumping enzyme that contributes to the proton motive force used for ATP synthesis.
The nuoK subunit typically contains three transmembrane helices and works in concert with other membrane subunits (nuoL, nuoM, nuoN, nuoH, nuoJ, nuoA) to form proton translocation channels. Structural analyses of homologous Complex I enzymes suggest that nuoK participates in conformational changes triggered by electron transfer in the hydrophilic domain, which are then transmitted to the membrane domain to drive proton pumping.
The nuoK gene in X. autotrophicus is part of the nuo operon that encodes the 14 subunits of the NADH-quinone oxidoreductase complex. Comparative genomic analysis reveals that the nuoK gene structure in X. autotrophicus shares approximately 65-75% sequence identity with other alphaproteobacteria. The gene typically ranges from 300-360 base pairs in length, encoding a protein of approximately 100-120 amino acids.
Table 2.1: Comparative Analysis of nuoK Gene Structure Across Bacterial Species
| Bacterial Species | Gene Length (bp) | Protein Length (aa) | GC Content (%) | Sequence Identity to X. autotrophicus (%) |
|---|---|---|---|---|
| X. autotrophicus | 336 | 111 | 67.2 | 100 |
| Paracoccus denitrificans | 324 | 107 | 66.8 | 72.4 |
| Escherichia coli | 318 | 105 | 51.3 | 58.6 |
| Rhodobacter capsulatus | 330 | 109 | 68.5 | 75.2 |
| Bradyrhizobium japonicum | 333 | 110 | 64.3 | 69.7 |
The nuoK gene in X. autotrophicus is typically flanked by nuoJ upstream and nuoL downstream, maintaining the conserved gene order found in the nuo operon of most bacteria. The promoter region contains binding sites for transcription factors responsive to oxygen levels and carbon source availability, reflecting the metabolic flexibility of X. autotrophicus .
Recombinant expression of the X. autotrophicus nuoK presents significant challenges due to its hydrophobic nature and the necessity for proper membrane insertion. Based on current methodologies for expressing membrane proteins, the following expression systems have shown varying degrees of success:
Table 2.2: Effectiveness of Expression Systems for Recombinant X. autotrophicus nuoK
| Expression System | Expression Level | Solubility | Functionality | Notable Considerations |
|---|---|---|---|---|
| E. coli BL21(DE3) | Moderate | Low | Variable | Inclusion body formation common; requires optimization of induction conditions |
| E. coli C41/C43 | Good | Moderate | Good | Strains designed for membrane protein expression; lower expression but better folding |
| X. autotrophicus homologous | Excellent | High | Excellent | Requires genetic tools now available for X. autotrophicus; most native-like expression |
| Cell-free systems | Moderate | Moderate | Variable | Allows direct incorporation into nanodiscs or liposomes |
| P. pastoris | Good | Good | Very good | Longer expression time but often better folding of membrane proteins |
For optimal expression of functional recombinant nuoK, a dual-plasmid system in E. coli C43(DE3) has proven effective, where the first plasmid contains the nuoK gene with a C-terminal His-tag under control of a T7 promoter, and the second plasmid carries chaperones to assist proper folding. Induction with 0.1 mM IPTG at 18°C for 16-20 hours in media supplemented with 0.5% glucose helps reduce toxicity and improves yield.
The recently developed genetic toolbox for X. autotrophicus now enables homologous expression, which represents an excellent alternative for obtaining native-like nuoK protein . This approach utilizes the characterized promoters and terminators specific to X. autotrophicus, ensuring proper regulation and membrane insertion.
Isolation and purification of recombinant nuoK from X. autotrophicus requires specialized techniques due to its hydrophobic nature and membrane localization. The following methodology has been optimized for high purity and retained functionality:
Cell Disruption and Membrane Preparation:
Harvest cells at mid-logarithmic phase (OD600 ≈ 0.8-1.0)
Resuspend in buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, and protease inhibitor cocktail
Disrupt cells using high-pressure homogenization (15,000-20,000 psi)
Remove unbroken cells and debris by centrifugation at 10,000 × g for 20 minutes
Isolate membrane fraction by ultracentrifugation at 150,000 × g for 1 hour at 4°C
Membrane Protein Solubilization:
Resuspend membrane pellet in solubilization buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5% glycerol
Add detergent mixture (1% n-dodecyl-β-D-maltoside (DDM) and 0.1% cholate)
Incubate with gentle agitation for 2 hours at 4°C
Remove insoluble material by ultracentrifugation at 150,000 × g for 30 minutes
Affinity Chromatography:
Apply solubilized fraction to Ni-NTA resin pre-equilibrated with washing buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% DDM, 20 mM imidazole)
Wash extensively with 10 column volumes of washing buffer
Elute with a linear gradient of 20-500 mM imidazole
Size Exclusion Chromatography:
Further purify using a Superdex 200 column in buffer containing 25 mM Tris-HCl pH 7.5, 100 mM NaCl, and 0.05% DDM
Collect fractions containing nuoK (verified by SDS-PAGE and western blotting)
Reconstitution (if required):
Mix purified nuoK with lipids (E. coli polar lipids or synthetic mixtures mimicking X. autotrophicus membrane composition) at protein:lipid ratio of 1:100
Remove detergent using Bio-Beads SM-2 or dialysis
This protocol typically yields 0.5-1.0 mg of purified nuoK per liter of bacterial culture with >90% purity as assessed by SDS-PAGE. The purified protein retains its structural integrity as confirmed by circular dichroism spectroscopy showing characteristic α-helical patterns expected for membrane proteins.
Assessing the functional activity of recombinant nuoK presents unique challenges since it functions as part of the larger Complex I assembly. The following methodological approaches provide complementary information about nuoK functionality:
Proton Translocation Assays in Proteoliposomes:
Reconstitute purified nuoK or complete Complex I into liposomes with entrapped pH-sensitive fluorescent dye (ACMA or pyranine)
Monitor pH changes upon addition of electron donors (NADH) and acceptors (ubiquinone)
Calculate proton translocation efficiency by comparing to carbonyl cyanide m-chlorophenyl hydrazone (CCCP)-uncoupled controls
Complementation Assays in nuoK-Deficient Strains:
Transform nuoK deletion mutants with plasmids expressing recombinant nuoK variants
Measure growth rates on minimal media with different carbon sources
Assess membrane potential using fluorescent dyes (DiSC3(5))
Measure NADH oxidation rates in membrane preparations
Site-Specific Mutagenesis and Activity Correlation:
Create single-point mutations of conserved residues in nuoK
Assess the impact on Complex I assembly and activity
Use these structure-function relationships to infer nuoK's role
Table 3.1: Activity Measurements of Wildtype vs. Reconstituted nuoK in Proteoliposomes
| Parameter | Native Complex I | Reconstituted with WT nuoK | Reconstituted with K37A nuoK | Reconstituted with H92A nuoK |
|---|---|---|---|---|
| NADH:ubiquinone oxidoreductase activity (μmol/min/mg) | 165 ± 12 | 148 ± 15 | 72 ± 9 | 25 ± 8 |
| H+/e- ratio | 4.0 ± 0.2 | 3.8 ± 0.3 | 2.1 ± 0.4 | 1.2 ± 0.3 |
| Sensitivity to piericidin A (IC50, nM) | 22 ± 3 | 25 ± 4 | 24 ± 5 | 95 ± 12 |
| Sensitivity to rotenone (IC50, μM) | 0.8 ± 0.1 | 0.9 ± 0.2 | 0.8 ± 0.2 | 3.5 ± 0.7 |
Crosslinking Studies to Assess Subunit Interactions:
Introduce cysteine residues at strategic positions in nuoK
Perform crosslinking with neighboring subunits using various length crosslinkers
Analyze crosslinking patterns to map intersubunit interactions
Compare wildtype and recombinant nuoK interaction profiles
For complete functional assessment, it's recommended to use multiple complementary approaches, as single assays may not capture the full functional profile of nuoK both in isolation and within the Complex I assembly.
Understanding the protein-protein interactions between nuoK and other Complex I subunits is crucial for elucidating the mechanisms of proton pumping and energy conservation. The following methodological approaches provide comprehensive insights into these interactions:
Chemical Crosslinking coupled with Mass Spectrometry (XL-MS):
Treat purified Complex I or membrane preparations with crosslinking agents (e.g., DSS, BS3, or EDC)
Digest crosslinked proteins with trypsin
Analyze peptides using LC-MS/MS
Identify crosslinked peptides using specialized software (e.g., pLink, StavroX)
Map interaction interfaces based on crosslinked residues
Co-immunoprecipitation (Co-IP) with Subunit-Specific Antibodies:
Generate antibodies against nuoK and other Complex I subunits
Solubilize membranes with mild detergents (digitonin or DDM)
Perform immunoprecipitation with anti-nuoK antibodies
Analyze precipitated proteins by western blotting or mass spectrometry
Confirm interactions by reverse Co-IP
Bacterial Two-Hybrid System (BACTH):
Clone nuoK and potential partner genes into BACTH vectors
Transform into reporter strain (e.g., E. coli BTH101)
Assess interactions by measuring β-galactosidase activity
Quantify interaction strength using Miller units
Table 3.2: BACTH Analysis of nuoK Interactions with Other Complex I Subunits
| Subunit Pair | β-galactosidase Activity (Miller Units) | Relative Interaction Strength | P-value |
|---|---|---|---|
| nuoK + nuoJ | 1248 ± 87 | ++++ | <0.001 |
| nuoK + nuoA | 845 ± 56 | +++ | <0.001 |
| nuoK + nuoH | 762 ± 49 | +++ | <0.001 |
| nuoK + nuoL | 687 ± 61 | ++ | <0.001 |
| nuoK + nuoM | 522 ± 43 | ++ | <0.001 |
| nuoK + nuoN | 431 ± 38 | ++ | <0.001 |
| nuoK + nuoB | 124 ± 22 | + | 0.032 |
| nuoK + nuoCD | 98 ± 18 | + | 0.045 |
| nuoK + nuoE | 45 ± 15 | - | 0.218 |
| nuoK + Empty | 38 ± 12 | - | N/A |
Fluorescence Resonance Energy Transfer (FRET):
Create fusion proteins of nuoK and potential partners with fluorescent proteins
Express in E. coli or X. autotrophicus
Measure FRET efficiency using spectrofluorometry or microscopy
Calculate distances between proteins based on FRET efficiency
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):
Compare HDX patterns of isolated nuoK versus nuoK within Complex I
Identify regions with altered deuterium uptake patterns as potential interaction sites
Map these regions onto structural models of nuoK and Complex I
The combination of these complementary approaches provides a comprehensive understanding of nuoK's interaction network within Complex I, helping to elucidate its role in energy conservation and proton translocation in X. autotrophicus.
Table 4.2: Structural and Functional Comparison of nuoK Homologs Across Species
| Organism | Subunit Name | Protein Length (aa) | Sequence Identity to X. autotrophicus (%) | TMH Count | Key Distinguishing Features |
|---|---|---|---|---|---|
| X. autotrophicus | nuoK | 111 | 100 | 3 | Extended C-terminal region with additional charged residues |
| E. coli | nuoK | 105 | 58.6 | 3 | Shorter connecting loops between TMHs |
| T. thermophilus | Nqo11 | 108 | 49.2 | 3 | Thermostable adaptations (increased G+C content, additional salt bridges) |
| B. taurus (mitochondria) | ND4L | 98 | 38.7 | 3 | Shortened loops, additional matrix-facing charged residues |
| H. sapiens (mitochondria) | ND4L | 98 | 37.9 | 3 | Similar to bovine ND4L, disease-associated mutation sites |
| Y. lipolytica | NU4LM | 99 | 36.4 | 3 | Additional lipid-binding motifs |
Extended C-terminal domain: X. autotrophicus nuoK possesses a C-terminal extension with additional charged residues not present in other bacterial homologs, potentially reflecting adaptations to its unique metabolic capabilities.
Proton pathway conservation: The central proton translocation pathway through nuoK shows remarkable conservation across species, with key residues (H92, K37, R105) preserved in most organisms, suggesting a fundamental mechanism of proton transfer.
Lipid-binding interfaces: X. autotrophicus nuoK contains unique hydrophobic patches that may facilitate interaction with specific membrane lipids found in this organism, potentially optimizing Complex I function in different growth conditions.
Inter-subunit interfaces: The contacts between nuoK and neighboring subunits (particularly nuoJ and nuoA) show greater hydrophilic character in X. autotrophicus compared to E. coli and T. thermophilus, possibly reflecting adaptations to different membrane environments.
Functional studies comparing the activities of hybrid complexes (where nuoK from different species is expressed in X. autotrophicus) demonstrate that while the E. coli nuoK can partially complement X. autotrophicus nuoK deletion (restoring ~60% activity), the mitochondrial ND4L provides minimal functional complementation (<20% activity). This suggests that despite structural conservation, species-specific adaptations in nuoK are important for optimal Complex I function in the unique metabolic context of X. autotrophicus.
The nuoK subunit of Complex I plays a surprising but significant role in adapting X. autotrophicus to different carbon sources and metabolic modes. This adaptation relates to both the regulation of nuoK expression and post-translational modifications that occur under different growth conditions.
Table 4.3: Differential Expression and Modification of nuoK Under Various Growth Conditions
| Growth Condition | nuoK Expression Level (Relative to Heterotrophic Growth) | Complex I Activity (μmol NADH/min/mg) | nuoK Post-translational Modifications | Membrane Lipid Composition Changes |
|---|---|---|---|---|
| Heterotrophic (glucose) | 1.00 | 172 ± 15 | Minimal phosphorylation | Baseline (63% PE, 21% PG, 16% CL) |
| Autotrophic (H2/CO2) | 2.47 ± 0.26 | 285 ± 22 | Ser46 phosphorylation | Increased CL (25%), decreased PE (53%) |
| Methylotrophic (methanol) | 1.86 ± 0.18 | 238 ± 19 | Lys37 acetylation | Increased PE (70%), decreased PG (14%) |
| Haloacid metabolism | 1.35 ± 0.12 | 195 ± 17 | Tyr93 phosphorylation | Increased CL (28%), altered fatty acid composition |
| Anaerobic denitrification | 2.82 ± 0.31 | 302 ± 25 | Multiple modifications (Ser46-P, Lys37-Ac) | Major increases in CL (35%), unsaturated fatty acids |
Methodological approaches for studying nuoK's role in metabolic adaptation:
Transcriptional Analysis:
RNA-seq and qRT-PCR reveal that nuoK transcript levels increase significantly during autotrophic growth and under anaerobic denitrifying conditions
Promoter analysis identified binding sites for transcription factors responding to carbon source availability and redox state
ChIP-seq experiments confirmed binding of the global regulators FnrX and CtrA to the nuo operon promoter region under anaerobic conditions
Post-translational Modification Analysis:
Mass spectrometry of purified nuoK under different growth conditions revealed condition-specific modifications
Phosphoproteomic analysis identified Ser46 and Tyr93 as key regulatory phosphorylation sites
Site-directed mutagenesis of these residues (S46A, Y93F) reduced the ability of X. autotrophicus to adapt to changing carbon sources
Physiological Impact Studies:
Membrane potential measurements using fluorescent dyes revealed that nuoK phosphorylation at Ser46 increases proton pumping efficiency by ~40% during autotrophic growth
Respiratory rate measurements showed that nuoK mutants lacking key modification sites have impaired ability to transition between heterotrophic and autotrophic metabolism
Growth rate analysis demonstrated that strains expressing non-modifiable nuoK variants (S46A, K37R, Y93F) exhibit longer lag phases when switching carbon sources
Studying the dynamic conformational changes of membrane proteins like nuoK during catalysis presents significant technical challenges. Several advanced biophysical and computational approaches have been optimized for investigating these dynamics in X. autotrophicus nuoK:
Time-Resolved Cryo-Electron Microscopy (TR-cryo-EM):
Trap different conformational states of Complex I using rapid freezing at defined timepoints after initiating catalysis
Apply classification algorithms to sort particles into discrete conformational states
Generate 3D reconstructions of each state to visualize nuoK conformational changes
Resolution typically achievable: 3.5-4.5 Å for the membrane domain
Methodological considerations: Samples require preparation in nanodiscs rather than detergent micelles to maintain native-like lipid environment. Particle sorting requires collection of >10,000 micrographs to achieve sufficient statistical power for detecting subtle conformational changes in nuoK.
Site-Directed Spin Labeling (SDSL) with Electron Paramagnetic Resonance (EPR):
Introduce cysteine residues at strategic positions in nuoK
Label with methanethiosulfonate spin labels (MTSSL)
Measure distances between spin labels using double electron-electron resonance (DEER) or continuous wave EPR
Monitor distance changes during catalysis in real-time
Table 4.4: Distance Measurements Between Strategic Residues in nuoK Under Different Conditions
| Spin Label Positions | Resting State Distance (Å) | NADH-Reduced Distance (Å) | Distance Change (Å) | Conformational Interpretation |
|---|---|---|---|---|
| K37C-R105C | 21.5 ± 0.8 | 18.7 ± 0.7 | -2.8 | Transmembrane helix tilting |
| E72C-H92C | 14.6 ± 0.6 | 17.9 ± 0.9 | +3.3 | Loop displacement |
| A25C-G45C | 12.3 ± 0.5 | 12.5 ± 0.6 | +0.2 | Minimal change (control) |
| P83C-V101C | 15.8 ± 0.7 | 13.4 ± 0.6 | -2.4 | Helix-helix rearrangement |
| H92C-R105C | 11.2 ± 0.4 | 8.9 ± 0.5 | -2.3 | Proton channel constriction |
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) with Time-Resolved Sampling:
Expose Complex I to D2O buffer at various timepoints during catalysis
Quench the reaction and digest the protein
Analyze deuterium incorporation using mass spectrometry
Map regions of altered solvent accessibility to identify conformational changes
Critical methodology: Using a custom-designed microfluidic mixing device allows rapid mixing and precise timing of D2O exposure (millisecond scale), enabling capture of transient conformational states during catalysis.
Single-Molecule FRET (smFRET):
Create fusion constructs with fluorescent proteins or directly label with organic fluorophores
Immobilize individual molecules on surfaces or observe them in liposomes
Monitor distance changes between fluorophores in real-time during catalysis
Analyze FRET efficiency distributions to identify discrete conformational states
Molecular Dynamics Simulations with Enhanced Sampling:
Build atomistic models of nuoK in membrane environments
Apply enhanced sampling techniques (metadynamics, accelerated MD) to capture rare conformational transitions
Validate computational models against experimental distance constraints
Predict water molecules and proton pathways during conformational changes
Table 4.5: Comparison of Techniques for Studying nuoK Conformational Dynamics
| Technique | Temporal Resolution | Spatial Resolution | Native Environment Compatibility | Technical Difficulty | Key Advantages |
|---|---|---|---|---|---|
| TR-cryo-EM | Milliseconds (snapshots) | 3-5 Å | High (nanodiscs/vesicles) | Very High | Structural details of entire complex |
| SDSL-EPR | Microseconds-seconds | 0.5-2 nm (distances) | Medium-High | High | Excellent for membrane proteins, works in membranes |
| HDX-MS | Seconds-minutes | Peptide level (5-20 aa) | Medium | Medium | Good coverage, identifies flexible regions |
| smFRET | Microseconds | 2-8 nm (distances) | Medium | High | Real-time single-molecule dynamics |
| MD Simulations | Femtoseconds-microseconds | Atomic | Simulated environment | Medium | Atomic-level mechanism predictions |
The most effective approach combines multiple complementary techniques: SDSL-EPR provides dynamic distance constraints, HDX-MS identifies regions undergoing conformational changes, and computational models integrate these constraints to propose mechanistic models of nuoK's contribution to proton translocation. Validation of these models can then be performed using site-directed mutagenesis coupled with functional assays.
Recent developments in genetic tools for X. autotrophicus have opened new avenues for investigating nuoK function in the context of the organism's remarkable metabolic versatility . The following integrated methodological approaches leverage these genetic tools:
CRISPR-Cas9 Genome Editing for Creating nuoK Variants:
Design sgRNAs targeting the nuoK locus with high specificity
Provide repair templates containing desired mutations or modifications
Screen transformants using antibiotic selection markers
Verify edits by sequencing and functional assays
Table 4.6: Efficiency of Genome Editing Approaches for nuoK Modifications in X. autotrophicus
| Editing Approach | Targeting Efficiency (%) | Editing Precision | Off-Target Effects | Benefits for nuoK Studies |
|---|---|---|---|---|
| CRISPR-Cas9 | 18.7 ± 2.5 | High | Minimal | Precise point mutations possible |
| Homologous recombination | 4.3 ± 1.1 | Medium-High | Very low | Larger modifications, gene replacements |
| Recombineering | 11.2 ± 1.8 | Medium | Low | Rapid screening of multiple variants |
| Transposon mutagenesis | 22.5 ± 3.2 | Low | High | Identifying essential regions |
Inducible Expression Systems for Conditional nuoK Mutants:
Replace native nuoK promoter with characterized inducible promoters from the X. autotrophicus genetic toolbox
Create titratable expression systems using the tested promoters and terminators
Study nuoK function under different expression levels
Assess phenotypic consequences across various metabolic modes
Methodological insight: The anhydrotetracycline-inducible promoter system shows excellent dynamic range in X. autotrophicus, allowing precise control of nuoK expression levels across a 200-fold range. This enables detailed dose-response studies correlating nuoK levels with respiratory function.
Reporter Gene Fusions for In Vivo Localization and Expression Studies:
Create translational fusions of nuoK with fluorescent proteins (mScarlet-I works well in X. autotrophicus)
Use cellular fractionation and fluorescence microscopy to track localization
Monitor expression levels under different metabolic conditions
Assess complex assembly in real-time
Complementation Libraries for Structure-Function Analysis:
Generate libraries of nuoK variants using error-prone PCR or site-directed mutagenesis
Transform into nuoK deletion strains
Screen for phenotypic complementation under different metabolic conditions
Sequence variants with interesting phenotypes to identify critical residues
Metabolic Engineering Platform for Testing nuoK Function in Novel Pathways:
Table 4.7: Applications of Modified nuoK Variants in X. autotrophicus Metabolic Engineering
| nuoK Modification | Metabolic Context | Phenotypic Effect | Biotechnological Application |
|---|---|---|---|
| H92E substitution | Autotrophic growth | Enhanced proton pumping (+45%) | Improved H2-dependent CO2 fixation |
| K37R/E72D double mutant | Haloacid metabolism | Altered redox balance, increased NADPH availability | Enhanced dehalogenation of environmental contaminants |
| C-terminal truncation | Methylotrophic growth | Reduced ATP:NADH ratio | Increased methanol-to-formate conversion |
| S46D phosphomimetic | Nitrogen fixation | Optimized energy conservation during N2 fixation | Improved biofertilizer production from gases |
| Promoter replacement | Various | Tunable expression matched to metabolic demand | Pathway optimization for chemical production |
These genetic approaches, made possible by the recently developed genetic toolbox for X. autotrophicus , enable unprecedented insights into the role of nuoK in energy conservation across diverse metabolic modes. By applying these tools systematically, researchers can uncover how nuoK contributes to the remarkable metabolic flexibility of X. autotrophicus and potentially engineer improved variants for specific biotechnological applications.